Kanagawa, Japan

Hajime Masumoto

This inventor holds 1 USPTO granted patent. Top assignees: Osaka University, Toray Industries, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajime Masumoto. Retrieved from https://idiyas.com/inventor/hajime-masumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hajime Masumoto: Innovator in Immunostimulatory Oligonucleotides

Introduction

Hajime Masumoto is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on immunostimulatory oligonucleotides. His research focuses on enhancing immune responses while minimizing inflammatory reactions.

Latest Patents

Masumoto holds a patent for "Immunostimulatory oligonucleotides and use thereof in pharmaceuticals." This invention presents a novel immunostimulatory oligonucleotide that enhances interferon-inducing activity while reducing inflammatory cytokine-inducing activity. The patent describes an oligonucleotide composed of a specific base sequence, which has applications in pharmaceuticals.

Career Highlights

Throughout his career, Hajime Masumoto has worked with prominent organizations such as Toray Industries, Inc. and Osaka University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of immunology and pharmaceuticals.

Collaborations

Masumoto has collaborated with notable colleagues, including Akiko Soneda and Tomokatsu Iwamura. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Hajime Masumoto's work in immunostimulatory oligonucleotides represents a significant advancement in pharmaceutical science. His innovative contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…